Compounds of the formula I
in which Het, R
3
and R
4
have the meanings indicated in Claim
1,
are inhibitors of RON and can be employed, for the treatment of cancer
US9283225B2
申请人:——
公开号:US9283225B2
公开(公告)日:2016-03-15
[EN] PYRIDO-PYRIMIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIDO-PYRIMIDINE
申请人:MERCK PATENT GMBH
公开号:WO2013022519A1
公开(公告)日:2013-02-14
Compounds of the formula I in which Het, R3 and R4 have the meanings indicated in Claim 1, are inhibitors of RON and can be employed, for the treatment of cancer.